{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T12:59:01Z","timestamp":1770555541822,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007161","name":"Secretar\u00eda de Investigaci\u00f3n y Posgrado, Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004431","name":"European Commission Directorate-General for Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015622","name":"Ministerul Cercet\u0103rii \u015fi Inov\u0103rii","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011941","name":"Government of Principality of Asturias","doi-asserted-by":"publisher","award":["IDE\/2024\/000733"],"award-info":[{"award-number":["IDE\/2024\/000733"]}],"id":[{"id":"10.13039\/100011941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","award":["PID2022-137893OB-I00"],"award-info":[{"award-number":["PID2022-137893OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI22\/00148"],"award-info":[{"award-number":["PI22\/00148"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bmcl.2026.130559","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:43:42Z","timestamp":1769013822000},"page":"130559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Organometallic gold(III) (C^S)-cyclometallated complexes as candidates to new drugs against chagas disease"],"prefix":"10.1016","volume":"134","author":[{"given":"Paula","family":"P\u00e9rez-Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogelio","family":"Gomez-Escobedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjam\u00edn","family":"Nogueda-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Moreno-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Llamedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Rodr\u00edguez-Solla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara M.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gildardo","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel G.","family":"Soengas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130559_bb0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01787-7","article-title":"Chagas disease","volume":"403","author":"de Sousa","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2026.130559_bb0010","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.3390\/ijms25073840","article-title":"Chagas disease: a silent threat for dogs and humans","volume":"25","author":"Dur\u00e3es-Oliveira","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2026.130559_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/AITC202302210","article-title":"Chagas disease","volume":"176","author":"Hochberg","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bmcl.2026.130559_bb0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1590\/0037-8682-0433-2016","article-title":"Chagas disease: review of needs, neglect, and obstacles to treatment. Access in Latin America","volume":"50","author":"Pinheiro","year":"2017","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.bmcl.2026.130559_bb0030","first-page":"464","article-title":"Chagas disease in Italy: the study\u2019s contribution of Italian researchers","volume":"61","author":"Antinori","year":"2019","journal-title":"Panminerva Med"},{"key":"10.1016\/j.bmcl.2026.130559_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010232","article-title":"Pediatric Chagas disease in the non-endemic area of Madrid: a fifteen-year review (2004\u20132018)","volume":"16","author":"Bravo-Gallego","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmcl.2026.130559_bb0040","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fpubh.2019.00166","article-title":"Chagas disease: from discovery to a worldwide health problem","volume":"7","author":"Lidani","year":"2019","journal-title":"Front Public Health"},{"key":"10.1016\/j.bmcl.2026.130559_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.07.009","volume":"5","author":"Forsyth","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.bmcl.2026.130559_bb0050","unstructured":"World Health Organization. Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021\u20132030. 2020. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240010352."},{"key":"10.1016\/j.bmcl.2026.130559_bb0055","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eimc.2020.04.011","article-title":"Trypanocidal treatment of Chagas disease","volume":"39","author":"Perez-Molina","year":"2021","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.bmcl.2026.130559_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012849","article-title":"Redefining the treatment of Chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox","volume":"19","author":"Altcheh","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmcl.2026.130559_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112020","article-title":"Advances in the treatment of Chagas disease: promising new drugs, plants and targets","volume":"142","author":"Garc\u00eda-Huertas","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2026.130559_bb0070","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3390\/jcm13092565","article-title":"Chagas disease: comparison of therapy with Nifurtimox and Benznidazole in indigenous communities in Colombia","volume":"13","author":"Kann","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.bmcl.2026.130559_bb0075","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1590\/0037-8682-0399-2016","volume":"50","author":"Olivera","year":"2017","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.bmcl.2026.130559_bb0080","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4269\/ajtmh.15-0256","article-title":"Safety profile of nifurtimox and treatment interruption for chronic Chagas disease in Colombian adults","volume":"93","author":"Olivera","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bmcl.2026.130559_bb0085","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/cid\/civ005","article-title":"Tolerance of benznidazole in a United States Chagas disease clinic","volume":"60","author":"Miller","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2026.130559_bb0090","doi-asserted-by":"crossref","first-page":"22639","DOI":"10.1073\/pnas.2007285117","article-title":"Gold-based therapy: from past to present","volume":"117","author":"Balfourier","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2026.130559_bb0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/jhmas\/jrg042","article-title":"The history of gold therapy for tuberculosis","volume":"59","author":"Benedek","year":"2004","journal-title":"J Hist Med Allied Sci"},{"key":"10.1016\/j.bmcl.2026.130559_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202218000","article-title":"Gold complexes in anticancer therapy: from new design principles to particle-based delivery systems","volume":"62","author":"Moreno-Alc\u00e1ntar","year":"2023","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2026.130559_bb0105","article-title":"Gold complexes: a new frontier in the battle against lung cancer. Reviews in inorganic chemistry. Gold complexes: a new frontier in the battle against lung cancer","author":"Hanif","year":"2024","journal-title":"Rev Inorg Chem"},{"key":"10.1016\/j.bmcl.2026.130559_bb0110","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/jm201416p","article-title":"Anti-inflammatory active gold(I) complexes involving 6-substituted-purine derivatives","volume":"55","author":"Tr\u00e1vn\u00ed\u010dek","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130559_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.846959","article-title":"Gold-derived molecules as new antimicrobial agents","volume":"13","author":"Ratia","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2026.130559_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215429","article-title":"Antibiotics: a \u201cGOLDen\u201d promise?","volume":"500","author":"Yeo","year":"2024","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.bmcl.2026.130559_bb0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.exppara.2015.05.012","article-title":"In vivo and in vitro auranofin activity against Trypanosoma cruzi: possible new uses for an old drug","volume":"166","author":"Alves da Silva","year":"2016","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.bmcl.2026.130559_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejmech.2016.05.003","article-title":"Gold(III) complexes with ONS-tridentate thiosemicarbazones: toward selective trypanocidal drugs","volume":"14","author":"Rettondin","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130559_bb0135","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1039\/C6DT04307K","article-title":"Organometallic gold(III) complexes with hybrid SNS-donating thiosemicarbazone ligands: cytotoxicity and anti-trypanosoma cruzi activity","volume":"8","author":"Maia","year":"2017","journal-title":"Dalton Trans"},{"key":"10.1016\/j.bmcl.2026.130559_bb0140","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1021\/acsinfecdis.8b00284","article-title":"Organometallic gold(III) complex [au(Hdamp)(L14)]+ (L1 = SNS-donating thiosemicarbazone) as a candidate to new formulations against Chagas disease","volume":"5","author":"Lopes","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmcl.2026.130559_bb0145","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.bcp.2007.07.022","article-title":"A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria","volume":"74","author":"Rackham","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130559_bb0150","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1039\/c1mt00053e","article-title":"Visualising gold inside tumour cells following treatment with an antitumour gold(I) complex","volume":"3","author":"Wedlock","year":"2011","journal-title":"Metallomics"},{"key":"10.1016\/j.bmcl.2026.130559_bb0155","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1504022112","article-title":"Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis","volume":"112","author":"Harbut","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2026.130559_bb0160","doi-asserted-by":"crossref","first-page":"1179354","DOI":"10.3389\/frabi.2023.1179354","article-title":"Gold complex compounds that inhibit drug-resistant Staphylococcus aureus by targeting thioredoxin reductase","volume":"2","author":"Tharmalingam","year":"2023","journal-title":"Front Antibiot"},{"key":"10.1016\/j.bmcl.2026.130559_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.663481","article-title":"Thioredoxin reductase is a valid target for antimicrobial therapeutic development against gram-positive bacteria","volume":"12","author":"Felix","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2026.130559_bb0170","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3389\/fmicb.2015.00975","article-title":"New drug target in protozoan parasites: the role of thioredoxin reductase","volume":"6","author":"Andrade","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2026.130559_bb0175","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1016\/j.bbagen.2013.01.013","article-title":"Trypanothione: a unique bis-glutathionyl derivative in trypanosomatids","volume":"1830","author":"Manta","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmcl.2026.130559_bb0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1432-1033.1987.tb11002.x","article-title":"Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme","volume":"164","author":"Krauth-Siegel","year":"1987","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bmcl.2026.130559_bb0185","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00726-011-0997-9","article-title":"A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition","volume":"42","author":"Ilari","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.bmcl.2026.130559_bb0190","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/cmdc.201300276","article-title":"Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes","volume":"8","author":"Colotti","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2026.130559_bb0195","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/acsinfecdis.9b00505","article-title":"Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors","volume":"6","author":"Tunes","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmcl.2026.130559_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1198473","article-title":"Novel gold(III)-dithiocarbamate complex targeting bacterial thioredoxin reductase: antimicrobial activity, synergy, toxicity, and mechanistic insights","volume":"14","author":"Ratia","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2026.130559_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2024.112735","volume":"262","author":"P\u00e9rez-Ramos","year":"2025","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.bmcl.2026.130559_bb0210","first-page":"1728","article-title":"Gold(III) complexes activity against multidrug-resistant bacteria of veterinary significance","volume":"12","author":"Sueiro","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmcl.2026.130559_bb0215","doi-asserted-by":"crossref","first-page":"15205","DOI":"10.1039\/D4DT01867B","volume":"53","author":"Llamedo","year":"2024","journal-title":"Dalton Trans"},{"key":"10.1016\/j.bmcl.2026.130559_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.815622","article-title":"A C^S-cyclometallated gold(III) complex as a novel antibacterial candidate against drug-resistant bacteria","volume":"13","author":"Ratia","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2026.130559_bb0225","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1039\/D4DT01184H","article-title":"Coordination of azol(in)ium dithiocarboxylate ligands to au(III): unexpected formation of a novel family of cyclometallated au(III) complexes, DFT calculations and catalytic studies","volume":"53","author":"P\u00e9rez-Ramos","year":"2024","journal-title":"Dalton Trans"},{"key":"10.1016\/j.bmcl.2026.130559_bb0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1087057114550585","article-title":"Chagas disease drug discovery: toward a new era","volume":"20","author":"Chatelain","year":"2015","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.bmcl.2026.130559_bb0235","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/molecules22020220","article-title":"Trypanocidal activity of quinoxaline 1,4 di-N-oxide derivatives as trypanothione reductase inhibitors","volume":"22","author":"Chac\u00f3n-Vargas","year":"2017","journal-title":"Molecules"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:18:20Z","timestamp":1770470300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"alternative-id":["S0960894X26000260"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130559","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organometallic gold(III) (C^S)-cyclometallated complexes as candidates to new drugs against chagas disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"130559"}}